Xience News
Most Popular Xience Story
Abbott's Xience enters tough stent market
FDA has given its final blessing to Abbott's Xience stent. Now what? Well, the drug-and-device maker will be entering a tough market, one roiled by debates over safety and questions about whether... Read more...
Latest Headlines
- October 13, 2008
- July 3, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
